FDA Reviewing Popular Peptides: What Researchers Should Know Before July 23

The FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to review BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon for the 503A Bulks List. Here's what the briefing documents already say, and what it does and doesn't mean for researchers.

Back to Blog